This paper is in the following e-collection/theme issue:

Adverse Drug Events Detection, Pharmacovigilance and Surveillance (214) Innovations and Technology in Cancer Care (525) Cancer Prognosis Models and Machine Learning (62) Decision Support for Health Professionals (1515) Clinical Information and Decision Making (1890)

Published on in Vol 13 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/72994, first published .
Model for Predicting Serious Hematological Adverse Events in Individuals With Ovarian Cancer Receiving Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Treatment: Prospective Cohort Study

Model for Predicting Serious Hematological Adverse Events in Individuals With Ovarian Cancer Receiving Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Treatment: Prospective Cohort Study

Model for Predicting Serious Hematological Adverse Events in Individuals With Ovarian Cancer Receiving Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Treatment: Prospective Cohort Study

Authors of this article:

Xiaotong Lian1 Author Orcid Image ;   Yu Lei2 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.